##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 82 Download : 79

##plugins.themes.academic_pro.article.main##

Abstract

The article presents clinical and genetic features and prognostic criteria for juvenile idiopathic arthritis. The clinical features of the disease, the results of laboratory analysis are important when choosing an effective method of treatment. Depending on the severity of the disease, the characteristics of the clinical course and the results of the functional laboratory analysis, drug and surgical treatment of joints is recommended

Keywords

juvenile idiopathic arthritis diagnosis prognosis

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Mallaev Sh.Sh, Sultanova N.S, Avezova G.S, & Faiziev N.N. (2023). Molecular-Genetic Mechanisms of the Development of Juvenile Idiopathic Arthritis in Children. Texas Journal of Medical Science, 19, 31–34. https://doi.org/10.62480/tjms.2023.vol19.pp31-34
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Kofiadi I.A., Rebrikov D.V. Methods for detection of single nucleotide polymorphisms: allele-specific PCR and hybridization with an oligonucleotide probe. Genetics 2006;42:22–32.
  2. Trofimov D.Yu., Ragimov A.A., Abramov D.D. Population-immunogenetic characteristic of the Russian population in terms of genetic polymorphisms significant for the human immune status. Fiziol patol immuno syst 2009;2:3–7.
  3. Sergeev I.V., Khaitov M.R., Trofimov D.Yu. Development of methods for conducting large-scale studies of polymorphism of genes that regulate various components of the immune response. Fiziol and patol immune systems 2009;4:6–10.
  4. Mallaev Sh.Sh, Bobomuratov TA, Fayziev NN, Sultanova NS, Dinmuxammadieva DR Genetic Aspects of Juvenile Rheumatoid Arthritis. ISSN (E): 2795 – 7624 VOLUME 10 | JULY 2022. 1-5.
  5. Sh.Sh Mallaev, AV Alimov Comparative efficacy of traditional therapy and chronotherapy in the treatment of juvenile rheumatoid arthritis. // New day in medicine - 2020. - T .1. No. 1 - S. 258-262.
  6. Sh.Sh Mallaev, A.V Alimov. Clinical course of juvenile rheumatoid arthritis and its optimization of treatment // Journal "Pediatrics" No. 2 Tashkent 2020. P. 200-203.
  7. Mallaev Sh.Sh., Alimov A.V. Clinical course of juvenile rheumatoid arthritis and its treatment optimization // Tibbiyotda yangi kun. - 2020. - No. 4 (32). - S. 68 -71. (14.00.00. - No. 22).
  8. Mallaev Sh.Sh., Alimov AV Clinic - laboratory manifestation of juvenile rheumatoid arthritis //Evroaziyskiy vestnik pediatrii. - 2020. - No. 3 - P. 56-60.
  9. Mallaev Sh.Sh.Modern features of the course of clinical variants of juvenile rheumatoid arthritis//Interuniversity Scientific Congress "Higher School: Scientific Research" Moscow, 2020. - P. 64 -65.
  10. Mallaev Sh.Sh.Substantiation of the chronopharmacological approach to the treatment of diffuse connective tissue diseases in children//Interuniversity Scientific Congress "Higher School: Scientific Research" Moscow, 2020. - P. 66 -67.
  11. Mallaev Sh.Sh., Alimov A.V. The functional state of the adrenal glands in children with juvenile rheumatoid arthritis // Collection of articles based on the materials of the XXXI International Scientific and Practical Conference No. 1 (28) Moscow 2020. - P. 76-80.
  12. Mallaev Sh.Sh., Alimov A.V. New approaches to the treatment of juvenile rheumatoid arthritis // Collection of articles based on the materials of the XXXI International Scientific and Practical Conference No. 2 (62) Moscow 2020. - P. 18-22.
  13. Guseva I., Panasyuk E., Soroka N. et al. The influence of the genetic polymorphisms on the response to treatment of active rheumatoid arthritis with Tocilizumab. Ann Rheum Dis 2011;70(Suppl 3):465.
  14. Wang J., Bansal A., Martin M. et al. Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis. Pharmacogenomics J 2012;13:1–7.
  15. Emery P., Dörner T. Optimizing treatment in rheumatoid arthritis: a rewiew of potential biological markers of response. Ann Rheum Dis 2011;70:2063–70.
  16. Bridges S.L. Jr. Personalized medicine in rheumatoid arthritis: hopes and challenges. Bull NYU Hosp Jt Dis 2007;65:174–7.
  17. Plenge RM, Cotsapas C., Davies L. et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007;39:1477–82.
  18. Thomson W., Bartpm A., Ke X. et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007;9:1431–3.
  19. Bowes J., Lawrence R., Eyre S. Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis. Hum Genet 2010;128:627–33.
  20. Dieguez-Gonzalez R., Calaza M., Perez-Pampin E. et al. Aalysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthr Res Ther 2009;11:R42.
  21. Shimane K., Kochi Y., Horita T. et al. The association of a non- synonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthr Rheum 2010;62:574–9.
  22. Vereecke L., Beyaert R., van Loo G. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. Biochem Soc Trans 2011;39:1086–91.
  23. Hushaaw LL, Sawaqed R., Sweis G. et al. Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis. Ther Clinical Risk Manag 2010;6:143–52.
  24. Patel AM, Moreland LW Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy. Drug Design Devel Ther 2010;4:263–78.
  25. Woodrick R., Ruderman EM Anti-interleukin-6 therapy in rheumatoid arthritis. Bull NYL Hosp J Dis 2010;68:211–7.
  26. Khodjamova N.K., Rakhmankulova Z.Zh., Tukhtaeva U.D. Features of the cytokine profile and apoptosis factors in newborn children with delay of in delayed intrauterine development// Journal of critical reviews. Kuala Lumpur, Malaysia. Vol 7, Issue 04. 2020. 1718-1724.
  27. Khodjamova N.K., Fayzullaeva D.B., Akhmedova Z.M. Characteristics of risk factors for intrauterine growth retardation in newborns born in asphyxia // International Student Scientific Bulletin. – 2020. – no. 2. - S. 14-14.
  28. Rakhmankulova Z. Zh., Khodjamova N. K., Kamalov Z. S. Features of the state of peripheral blood in very premature babies // Journal of Theoretical and Clinical Medicine. – 2022. – no. 2. - S. 56-61.
  29. Khodjamova N.K., Ismailova M.A. Features of the course of the neonatal period in newborns with congenital malformations of the upper gastrointestinal tract //Academic research in educational sciences. – 2023. – no. 1. - S. 206-212.
  30. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 1988;31:315–24.
  31. Faiziev, N. N., Mallaev, Sh. Sh., Sultanova, N. S., & Bobomuratov, T. A. (2023). Changes in the hemostasis system in children with pneumonia and optimization of their treatment.

Most read articles by the same author(s)